SUGAR LAND--February 28, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Virtually every corner of North America will house a portion of $4.2 billion in capital and maintenance (MRO) projects for the Pharmaceutical-Biotech Industry in first-quarter 2013. A recent survey taken from Industrial Info's Pharmaceutical Tracker - Online Database forecasts 145 projects with a cumulative total investment value (TIV) of $4.2 billion that are ready to begin construction during the quarter. Other companies featured: Baxter International Corporation (NYSE:BAX) , Merck & Company's (NYSE:MRK) , Pfizer Incorporated (NYSE:PFE)